Literature DB >> 21968750

Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.

Rodrigo P Pedrosa1, Luciano F Drager, Carolina C Gonzaga, Marcio G Sousa, Lílian K G de Paula, Aline C S Amaro, Celso Amodeo, Luiz A Bortolotto, Eduardo M Krieger, T Douglas Bradley, Geraldo Lorenzi-Filho.   

Abstract

Recognition and treatment of secondary causes of hypertension among patients with resistant hypertension may help to control blood pressure and reduce cardiovascular risk. However, there are no studies systematically evaluating secondary causes of hypertension according to the Seventh Joint National Committee. Consecutive patients with resistant hypertension were investigated for known causes of hypertension irrespective of symptoms and signs, including aortic coarctation, Cushing syndrome, obstructive sleep apnea, drugs, pheochromocytoma, primary aldosteronism, renal parenchymal disease, renovascular hypertension, and thyroid disorders. Among 125 patients (age: 52±1 years, 43% males, systolic and diastolic blood pressure: 176±31 and 107±19 mm Hg, respectively), obstructive sleep apnea (apnea-hypopnea index: >15 events per hour) was the most common condition associated with resistant hypertension (64.0%), followed by primary aldosteronism (5.6%), renal artery stenosis (2.4%), renal parenchymal disease (1.6%), oral contraceptives (1.6%), and thyroid disorders (0.8%). In 34.4%, no secondary cause of hypertension was identified (primary hypertension). Two concomitant secondary causes of hypertension were found in 6.4% of patients. Age >50 years (odds ratio: 5.2 [95% CI: 1.9-14.2]; P<0.01), neck circumference ≥41 cm for women and ≥43 cm for men (odds ratio: 4.7 [95% CI: 1.3-16.9]; P=0.02), and presence of snoring (odds ratio: 3.7 [95% CI: 1.3-11]; P=0.02) were predictors of obstructive sleep apnea. In conclusion, obstructive sleep apnea appears to be the most common condition associated with resistant hypertension. Age >50 years, large neck circumference measurement, and snoring are good predictors of obstructive sleep apnea in this population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968750     DOI: 10.1161/HYPERTENSIONAHA.111.179788

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  172 in total

1.  Does age elevate blood pressure in obstructive sleep apnea?

Authors:  Ma Wei; Chen Hui; Zhen-hua Gao
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-30       Impact factor: 2.503

2.  Sleep apnoea: a major and under-recognised public health concern.

Authors:  Walter T McNicholas; Yuanming Luo; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 3.  Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Christopher P O'Donnell; Sergio L Cravo; Geraldo Lorenzi-Filho; Benedito H Machado
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

4.  [Resistant hypertension : What is it?].

Authors:  F C Luft
Journal:  Internist (Berl)       Date:  2015-03       Impact factor: 0.743

5.  Acute pulmonary embolism in patients with obstructive sleep apnea: frequency, hospital outcomes, and recurrence.

Authors:  Zeynep Idil Seckin; Haytham Helmi; Timothy J Weister; Augustine Lee; Emir Festic
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

Review 6.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

Review 7.  How can resistant hypertension be identified and prevented?

Authors:  Anna Solini; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2013-03-05       Impact factor: 32.419

8.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

9.  Impact of Sleep-Disordered Breathing Treatment on Patient Reported Outcomes in a Clinic-Based Cohort of Hypertensive Patients.

Authors:  Harneet K Walia; Sandra D Griffith; Nicolas R Thompson; Douglas E Moul; Nancy Foldvary-Schaefer; Reena Mehra
Journal:  J Clin Sleep Med       Date:  2016-10-15       Impact factor: 4.062

Review 10.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.